1,4,7-triazacyclononane-n,n',n''-triacetic acid and Carcinoma, Epidermoid

1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with Carcinoma, Epidermoid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baechler, S; Buchegger, F; Dunet, V; Kosinski, M; Poitry-Yamate, C; Prior, JO; Rüegg, C; Viertl, D	1

Other Studies

1 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and Carcinoma, Epidermoid

Article	Year
68Ga-NODAGA-RGDyK for αvβ3 integrin PET imaging. Preclinical investigation and dosimetry. Nuklearmedizin. Nuclear medicine, 2011, Volume: 50, Issue:6 Topics: Animals; Body Burden; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Metabolic Clearance Rate; Mice; Mice, Inbred ICR; Oligopeptides; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole-Body Counting	2011

Article

Year

68Ga-NODAGA-RGDyK for αvβ3 integrin PET imaging. Preclinical investigation and dosimetry.

Nuklearmedizin. Nuclear medicine, 2011, Volume: 50, Issue:6

Topics: Animals; Body Burden; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Metabolic Clearance Rate; Mice; Mice, Inbred ICR; Oligopeptides; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole-Body Counting

2011